Refining analyses of copy number variation identifiesspecific genes associated with developmental delay

Copy number variants (CNVs) are associated with many neurocognitive disorders; however, these events are typically
large, and the underlying causative genes are unclear. We created an expanded CNV morbidity map from 29,085 children
with developmental delay in comparison to 19,584 healthy controls, identifying 70 significant CNVs. We resequenced 26
candidate genes in 4,716 additional cases with developmental delay or autism and 2,193 controls. An integrated analysis of
CNV and single-nucleotide variant (SNV) data pinpointed 10 genes enriched for putative loss of function. Follow-up of a subset
of affected individuals identified new clinical subtypes of pediatric disease and the genes responsible for disease-associated
CNVs. These genetic changes include haploinsufficiency of SETBP1 associated with intellectual disability and loss of expressive
language and truncations of ZMYND11 in individuals with autism, aggression and complex neuropsychiatric features.

This combined CNV and SNV approach facilitates the rapid discovery of new syndromes and genes involved in neuropsychiatric
disease despite extensive genetic heterogeneity.

Author

Bradley P Coe | Kali Witherspoon | Jill A Rosenfeld | Bregje W M van Bon | Anneke T Vulto-van Silfhout | Paolo Bosco | Kathryn L Friend | Carl Baker | Serafino Buono | Lisenka E L M Vissers | Janneke H Schuurs-Hoeijmakers | Alex Hoischen | Rolph Pfundt | Nik Krumm | Gemma L Carvill | Deana Li | David Amaral | Natasha Brown | Paul J Lockhart | Ingrid E Scheffer | Antonino Alberti | Marie Shaw | Rosa Pettinato | Raymond Tervo | Nicole de Leeuw | Margot R F Reijnders | Beth S Torchia | Hilde Peeters | Brian J O’Roak | Marco Fichera | Jayne Y Hehir-Kwa | Jay Shendure | Heather C Mefford | Eric Haan | Jozef Gécz | Bert B A de Vries | Corrado Romano | Evan E Eichler

The Project 8p Foundation (Project 8p) was created in 2018 to:

  • Accelerate future treatments, not only for 8p, but potentially for other chromosome-wide diseases as well.
  • Lead with knowledge from patients. Currently, there is no cure for 8p disorders, nor is there a standard course of treatment.

The Project 8p Foundation (Project 8p) was created in 2018 to:

  • Raise transformative funding for pioneering scientific research into treatments for a complex, rare disease involving 250+ affected genes on the short arm of the 8 th chromosome (8p). Rearrangements of these genes causes significant abnormalities to the entire neurological system, thus all organs and functions of the body– with variance in cognitive functions, gross motor skills, social development and other challenges during infancy, and throughout life;
  • Empower a unified community of 8p patients and their families so they can have meaningful lives today; and
  • Accelerate future treatments, not only for 8p, but potentially for other chromosome-wide diseases as well.